Exploring and exploiting the systemic effects of deregulated replication licensing

Seminars in Cancer Biology

Volumn 37-38, Issue , 2016, Pages 3-15

  Petrakis, Theodoros G ^a   Komseli, Eirini Stavroula ^a   Papaioannou, Marilena ^a   Vougas, Kostas ^b   Polyzos, Alexandros ^b   Myrianthopoulos, Vassilios ^c   Mikros, Emmanuel ^c   Trougakos, Ioannis P ^c   Thanos, Dimitris ^b   Branzei, Dana ^d   Townsend, Paul ^e   Gorgoulis, Vassilis G ^a,b,e  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^c UNIVERSITY OF ATHENS   (Greece)

^d FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

^e UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Cancer; Cdc6; Cdt1; Replication licensing factors; Replication stress

Indexed keywords

CELL CYCLE PROTEIN 6; CYCLIN E; MYC PROTEIN; REPLICATION FACTOR A; REPLICATION LICENSING FACTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR CTCF; TRANSCRIPTION FACTOR E2F; UNCLASSIFIED DRUG; UVOMORULIN;

3' UNTRANSLATED REGION; BINDING SITE; CANCER GROWTH; CARCINOGENESIS; DNA REPLICATION; EPITHELIAL MESENCHYMAL TRANSITION; EXON; GENE EXPRESSION REGULATION; GENE MUTATION; GENETIC DISORDER; GENETIC TRANSCRIPTION; GENOMIC INSTABILITY; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MEIER GORLIN SYNDROME; NONHUMAN; REPLICATION LICENSING; REVIEW; TRANSCRIPTION REGULATION; TRANSCRIPTIONAL REPROGRAMMING; WARSAW BREAKAGE SYNDROME; GENETICS; NEOPLASM;

DNA REPLICATION; GENE EXPRESSION REGULATION; GENOMIC INSTABILITY; HUMANS; NEOPLASMS;

EID: 84953432545     PISSN: 1044579X     EISSN: 10963650     Source Type: Journal    
DOI: 10.1016/j.semcancer.2015.12.002     Document Type: Review

References (131)

1. Halazonetis T.D., Gorgoulis V.G., Bartek J. An oncogene-induced DNA damage model for cancer development. Science 2008, 319:1352-1355. 10.1126/science.1140735.
2. Gorgoulis V.G., Vassiliou L.V., Karakaidos P., Zacharatos P., Kotsinas A., Liloglou T., et al. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 2005, 434:907-913. 10.1038/nature03485.
3. Bartkova J., Rezaei N., Liontos M., Karakaidos P., Kletsas D., Issaeva N., et al. Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 2006, 444:633-637. 10.1038/nature05268.
4. Negrini S., Gorgoulis V.G., Halazonetis T.D. Genomic instability-an evolving hallmark of cancer. Nat. Rev. Mol. Cell Biol. 2010, 11:220-228. 10.1038/nrm2858.
5. Baker T.A., Bell S.P. Polymerases and the replisome machines within machines. Cell 1998, 92:295-305.
6. Hill T.M., Kopp B.J., Kuempe1 P.K. Termination of DNA replication in Escherichia coli requires a transacting factor. J. Bacteriol. 1988, 170:662-668.
7. Greider C.W., Blackburn E.H. The telomere terminal transferase of Tetrahymena is a ribonucleoprotein enzyme with two kinds of primer specificity. Cell 1987, 51:887-898.
8. Branzei D., Foiani M. Maintaining genome stability at the replication fork. Nat. Rev. Mol. Cell Biol. 2010, 11:208-219. 10.1038/nrm2852.
9. Barry E.R., Bell S.D. DNA replication in the archaea. Microbiology and Molecular Biology Reviews 2006, 70:876-887. 10.1128/MMBR. 00029-06.
10. Gao F., Zhang C.-T., Dori C. A database of oriC regions in bacterial genomes. Bioinformatics 2007, 23:1866-1867.
11. Cvetic C., Walter J.C. Eukaryotic origins of DNA replication: could you please be more specific?. Semin. Cell Dev. Biol. 2005, 16:343-353. 10.1016/j.semcdb.2005.02.009.
12. Mechali M., Eukaryotic D.N.A. replication origins: many choices for appropriate answers. Nat. Rev. Mol. Cell Biol. 2010, 11:728-738.
13. Leonard A.C., Méchali M. DNA replication origins. Cold Spring Harbor Perspect. Biol. 2013, 5(10):a010116. 10.1101/cshperspect.a010116.
14. Cayrou C., Coulombe P., Vigneron A., Stanojcic S., Ganier O., Peiffer I., et al. Genome-scale analysis of metazoan replication origins reveals their organization in specific but flexible sites defined by conserved features. Genome Res. 2011, 21:1438-1449. 10.1101/gr.121830.111.
15. DePamphilis M.L., Blow J.J., Ghosh S., Saha T., Noguchi K., Vassilev A. Regulating the licensing of DNA replication origins in metazoa. Curr. Opin. Cell Biol. 2006, 18:231-239.
16. Feng D., Tu Z., Wu W., Liang C. Inhibiting the expression of DNA replication-initiation proteins induces apoptosis in human cancer cells. Cancer Res. 2003, 63:7356-7364.
17. Liu P., Slater D.M., Lenburg M., Nevis K., Cook J.G., Vaziri C. Replication licensing promotes cyclin D1 expression and G1 progression in untransformed human cells. Cell Cycle 2009, 8:125-136.
18. Machida Y.J., Teer J.K., Dutta A. Acute reduction of an origin recognition complex (ORC) subunit in human cells reveals a requirement of ORC for Cdk2 activation. J. Biol. Chem. 2005, 280:27624-27630.
19. Nevis K.R., Cordeiro-Stone M., Cook J.G. Origin licensing and p53 status regulate Cdk2 activity during G(1). Cell Cycle 2009, 8:1952-1963.
20. Borlado L.R., Méndez J. CDC6: from DNA replication to cell cycle checkpoints and oncogenesis. Carcinogenesis 2008, 29:237-243. 10.1371/journal.pone.0137259.
21. Takayama Y., Kamimura Y., Okawa M., Muramatsu S., Sugino A., Araki H. GINS, a novel multiprotein complex required for chromosomal DNA replication in budding yeast. Genes Dev. 2003, 17:1153-1165. 10.1101/gad.1065903.
22. Tanaka S., Araki H. Helicase activation and establishment of replication forks at chromosomal origins of replication. Cold Spring Harbor Perspect. Biol. 2013, 5(12):a010371. 10.1101/cshperspect.a010371.
23. Teer J.K., Dutta A. Regulation of S phase. Results Probl. Cell Differ. 2006, 42:31-63.
24. Petersen B.O., Wagener C., Marinoni F., Kramer E.R., Melixetian M., Lazzerini Denchi E., et al. Cell cycle - and cell growth - regulated proteolysis of mammalian CDC6 is dependent on APC-CDH1. Genes Dev. 2000, 14:2330-2343.
25. Hall J.R., Kow E., Nevis K.R., Lu C.K., Luce K.S., Zhong Q., et al. Cdc6 stability is regulated by the huwe1 ubiquitin ligase after DNA damage. Mol. Biol. Cell 2007, 18:3340-3350. 10.1091/mbc.E07-02-0173.
26. Sugimoto N., Yoshida K., Tatsumi Y., Yugawa T., Narisawa-Saito M., Waga S., Kiyono T., et al. Redundant and differential regulation of multiple licensing factors ensures prevention of re-replication in normal human cells. J. Cell Sci. 2009, 122:1184-1191. 10.1242/jcs.041889.
27. Blow J.J., Dutta A. Preventing re-replication of chromosomal DNA. Nat. Rev. Mol. Cell Biol. 2005, 6:476-486. 10.1038/nrm1663.
28. Hills S.A., Diffley J.F. DNA replication and oncogene-induced replicative stress. Curr. Biol. 2014, 24:R435-R444. 10.1016/j.cub.2014.04.012.
29. Truong L.N., Wu X. Prevention of DNA re-replication in eukaryotic cells. J. Mol. Cell. Biol. 2011, 3:13-22. 10.1093/jmcb/mjq052.
30. Zielke N., Edgar B.A., DePamphilis M.L. Endoreplication. Cold Spring Harbor Perspect. Biol. 2013, 5(1):a012948. 10.1101/cshperspect.a012948.
31. Ullah Z., Lee C.Y., DePamphilis M.L. Cip/Kip cyclin-dependent protein kinase inhibitors and the road to polyploidy. Cell Div. 2009, 4:10. 10.1186/1747-1028-4-10.
32. Vilaboa N., Bermejo R., Martinez P., Bornstein R., Calés C. A novel E2 box-GATA element modulates Cdc6 transcription during human cells polyploidization. Nucleic Acids Res. 2004, 32:6454-6467. 10.1093/nar/gkh981.
33. Karakaidos P., Taraviras S., Vassiliou L.V., Zacharatos P., Kastrinakis N.G., Kougiou D., et al. Overexpression of the replication licensing regulators hCdt1 and hCdc6 characterizes a subset of non-small-cell lung carcinomas: synergistic effect with mutant p53 on tumor growth and chromosomal instability-evidence of E2F-1 transcriptional control over hCdt1. Am. J. Pathol. 2004, 165:1351-1365.
34. Liontos M., Koutsami M., Sideridou M., Evangelou K., Kletsas D., Levy B., et al. Deregulated overexpression of hCdt1 and hCdc6 promotes malignant behavior. Cancer Res. 2007, 67:10899-10909. 10.1158/0008-5472.CAN-07-2837.
35. Hua C., Zhao G., Li Y., Bie L. Minichromosome maintenance (MCM) family as potential diagnostic and prognostic tumor markers for human gliomas. BMC Cancer 2014, 14:526. 10.1186/1471-2407-14-526.
36. Das M., Prasad S.B., Yadav S.S., Govardhan H.B., Pandey L.K., Singh S., et al. Over Expression of minichromosome maintenance genes is clinically correlated to cervical carcinogenesis. PLoS ONE 2013, 8(7):e69607. 10.1371/journal.pone.0069607.
37. Lau K.M., Chan Q.K., Pang J.C., Li K.K., Yeung W.W., Chung N.Y., et al. Minichromosome maintenance proteins 2, 3 and 7 in medulloblastoma: overexpression and involvement in regulation of cell migration and invasion. Oncogene 2010, 29:5475-5489. 10.1038/onc.2010.287.
38. Evangelou K., Havaki S., Kotsinas A. E2F transcription factors and digestive system malignancies: how much do we know?. World J. Gastroenterol.: WJG 2014, 20:10212-10216. 10.3748/wjg.v20.i29.10212.
39. Tsantoulis P.K., Gorgoulis V.G. Involvement of E2F transcription factor family in cancer. Eur. J. Cancer 2005, 41:2403-2414. 10.1016/j.ejca.2005.08.005.
40. Ho A., Dowdy S.F. Regulation of G(1) cell-cycle progression by oncogenes and tumor suppressor genes. Curr. Opin. Genet. Dev. 2002, 12:47-52.
41. Akman B.H., Can T., Erson-Bensan A.E. Estrogen-induced upregulation and 3'-UTR shortening of CDC6. Nucleic Acids Res. 2012, 40:10679-10688. 10.1093/nar/gks855.
42. Greenblatt M.S., Bennett W.P., Hollstein M., Harris C.C. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res. 1994, 54:4855-4878.
43. Bicknell L.S., Bongers E.M., Leitch A., Brown S., Schoots J., Harley M.E., et al. Mutations in the pre-replication complex cause Meier-Gorlin syndrome. Nat. Genet. 2011, 43:356-359. 10.1038/ng.775.
44. De Munnik S.A., Bicknell L.S., Aftimos S., Al-Aama J.Y., van Bever Y., Bober M.B., et al. Meier-Gorlin syndrome genotype-phenotype studies: 35 individuals with pre-replication complex gene mutations and 10 without molecular diagnosis. Eur. J. Hum. Genet. 2012, 20:598-606. 10.1038/ejhg.2011.269.
45. Gineau L., Cognet C., Kara N., Lach F.P., Dunne J., Veturi U., et al. Partial MCM4 deficiency in patients with growth retardation, adrenal insufficiency, and natural killer cell deficiency. J. Clin. Invest. 2012, 122:821-832. 10.1172/JCI61014.
46. Hughes C.R., Guasti L., Meimaridou E., Chuang C.H., Schimenti J.C., King P.J., et al. MCM4 mutation causes adrenal failure, short stature, and natural killer cell deficiency in humans. J. Clin. Invest. 2012, 122:814-820. 10.1172/JCI60224.
47. Capo-Chichi J.-M., Kumar Bharti S., Sommers J.A., Chouery E., Patry L., Rouleau G.A., et al. Identification and biochemical characterization of a novel mutation in DDX11 causing Warsaw breakage syndrome. Hum. Mutat. 2013, 34:103-107. 10.1002/humu.22226.
48. Ma L., Zhai Y., Feng D., Chan T.C., Lu Y., Fu X., et al. Identification of novel factors involved in or regulating initiation of DNA replication by a genome-wide phenotypic screen in Saccharomyces cerevisiae. Cell Cycle 2010, 9:4399-4410.
49. Allen C., Ashley A.K., Hromas R., Nickoloff J.A. More forks on the road to replication stress recovery. J. Mol. Cell. Biol. 2011, 3:4-12. 10.1093/jmcb/mjq049.
50. Di Micco R., Fumagalli M., Cicalese A., Piccinin S., Gasparini P., Luise C., et al. Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature 2006, 444:638-642.
51. Bester A.C., Roniger M., Oren Y.S., Im M.M., Sarni D., Chaoat M., et al. Nucleotide deficiency promotes genomic instability in early stages of cancer development. Cell 2011, 145:435-446. 10.1016/j.cell.2011.03.044.
52. Dominguez-Sola D., Ying C.Y., Grandori C., Ruggiero L., Chen B., Li M., et al. Non-transcriptional control of DNA replication by c-Myc. Nature 2007, 448:445-451.
53. Jones R.M., Mortusewicz O., Afzal I., Lorvellec M., Garcia P., Helleday T., et al. Increased replication initiation and conflicts with transcription underlie Cyclin E-induced replication stress. Oncogene 2012, 32:3744-3753. 10.1038/onc.2012.387.
54. Vlach J., Hennecke S., Alevizopoulos K., Conti D., Amati B. Growth arrest by the cyclin-dependent kinase inhibitor p27Kip1 is abrogated by c-Myc. EMBO J. 1996, 15:6595-6604.
55. Davidson I.F., Li A., Blow J.J. Deregulated replication licensing causes DNA fragmentation consistent with head-to-tail fork collision. Mol. Cell 2006, 24:433-443. 10.1016/j.molcel.2006.09.010.
56. Helmrich A., Ballarino M., Nudler E., Tora L. Transcription-replication encounters, consequences and genomic instability. Nat. Struct. Mol. Biol. 2013, 20:412-418. 10.1038/nsmb.2543.
57. Vaziri C., Saxena S., Jeon Y., Lee C., Murata K., Machida Y., et al. A p53-dependent checkpoint pathway prevents re-replication. Mol. Cell 2003, 11:997-1008.
58. Ekholm-Reed S., Méndez J., Tedesco D., Zetterberg A., Stillman B., Reed S.I. Deregulation of cyclin E in human cells interferes with pre-replication complex assembly. J. Cell Biol. 2004, 165:789-800. 10.1083/jcb.200404092.
59. Mehta A., Haber J.E. Sources of DNA double-strand breaks and models of recombinational DNA repair. Cold Spring Harbor Perspect. Biol. 2014, 6:a016428. 10.1101/cshperspect.a016428.
60. Doksani Y., Bermejo R., Fiorani S., Haber J.E., Foiani M. A single S phase double-strand break influences replicon dynamics and triggers a Mre11-Tel1/ATM-mediated mechanism controlling terminal fork integrity. Cell 2009, 137:247-258. 10.1016/j.cell.2009.02.016.
61. Ottaviani D., LeCain M., Sheer D. The role of microhomology in genomic structural variation. Trends Genet. 2014, 30:85-94. 10.1016/j.tig.2014.01.001.
62. Lee J.A., Carvalho C.M., Lupski J.R. A DNA replication mechanism for generating nonrecurrent rearrangements associated with genomic disorders. Cell 2007, 131:123547.
63. Zhang F., Khajavi M., Connolly A.M., Towne C.F., Batish S.D., Lupski J.R., The D.N.A. replication FoSTeS/MMBIR mechanism can generate genomic, genic and exonic complex rearrangements in humans. Nat. Genet. 2009, 41:849-853. 10.1038/ng.399.
64. Macheret M., Halazonetis T.D. DNA replication stress as a hallmark of cancer. Annu. Rev. Pathol. 2015, 10:425-448. 10.1146/annurev-pathol-012414-040424.
65. Ozeri-Galai E., Tur-Sinai M., Bester A.C., Kerem B. Interplay between genetic and epigenetic factors governs common fragile site instability in cancer. Cell Mol. Life Sci. 2014, 71:4495-4506. 10.1007/s00018-014-1719-8.
66. Franchitto A., Pichierri P. Replication fork recovery and regulation of common fragile sites stability. Cell Mol. Life Sci. 2014, 71:4507-4517. 10.1007/s00018-014-1718-9.
67. Lukas C., Savic V., Bekker-Jensen S., Doil C., Neumann B., Pedersen R.S., et al. 53BP1 nuclear bodies form around DNA lesions generated by mitotic transmission of chromosomes under replication stress. Nat. Cell Biol. 2011, 13:243-253. 10.1038/ncb2201.
68. Palakodeti A., Lucas I., Jiang Y., Young D.J., Fernald A.A., Karrison T., et al. Impaired replication dynamics at the FRA3B common fragile site. Hum. Mol. Genet. 2010, 19:99-110. 10.1093/hmg/ddp470.
69. Barlow J.H., Faryabi R.B., Callén E., Wong N., Malhowski A., Chen H.T., et al. Identification of early replicating fragile sites that contribute to genome instability. Cell 2013, 152:620-632. 10.1016/j.cell.2013.01.006.
70. Georgakilas A.G., Tsantoulis P., Kotsinas A., Michalopoulos I., Townsend P., Gorgoulis V.G. Are common fragile sites merely structural domains or highly organized "functional" units susceptible to oncogenic stress?. Cell Mol. Life Sci. 2014, 71:4519-4544. 10.1007/s00018-014-1717-x.
71. Sideridou M., Zakopoulou R., Evangelou K., Liontos M., Kotsinas A., Rampakakis E., et al. Cdc6 expression represses E-cadherin transcription and activates adjacent replication origins. J. Cell Biol. 2011, 195:1123-1140. 10.1083/jcb.201108121.
72. Rogakou E.P., Pilch D.R., Orr A.H., Ivanova V.S., Bonner W.M. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J. Biol. Chem. 1998, 273:5858-5868.
73. Cheng Q., Chen J. Mechanism of p53 stabilization by ATM after DNA damage. Cell Cycle 2010, 9:472-478.
74. Zhang Y., Xiong Y., Yarbrough W.G. ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell 1998, 92:725-734.
75. Gonzalez S., Klatt P., Delgado S., Conde E., Lopez-Rios F., Sanchez-Cespedes M., et al. Oncogenic activity of Cdc6 through repression of the INK4/ARF locus. Nature 2006, 440:702-706.
76. Collado M., Blasco M.A., Serrano M. Cellular senescence in cancer and aging. Cell 2007, 130:223-233.
77. Velimezi G., Liontos M., Vougas K., Roumeliotis T., Bartkova J., Sideridou M., et al. Functional interplay between the DNA-damage-response kinase ATM and ARF tumour suppressor protein in human cancer. Nat. Cell Biol. 2013, 15:967-977. 10.1038/ncb2795.
78. Bicknell L.S., Walker S., Klingseisen A., Stiff T., Leitch A., Kerzendorfer C., et al. Mutations in ORC1, encoding the largest subunit of the origin recognition complex, cause microcephalic primordial dwarfism resembling Meier-Gorlin syndrome. Nat. Genet. 2011, 43:350-355. 10.1038/ng.776.
79. Stiff T., Alagoz M., Alcantara D., Outwin E., Brunner H.G., Bongers E.M., et al. Deficiency in origin licensing proteins impairs cilia formation: implications for the aetiology of Meier-Gorlin syndrome. PLoS Genet. 2013, 9(3):e1003360. 10.1371/journal.pgen.1003360.
80. O'Riordan S.M., Lynch S.A., Hindmarsh P.C., Chan L.F., Clark A.J., Costigan C. A novel variant of familial glucocorticoid deficiency prevalent among the Irish Traveler population. J. Clin. Endocrinol. Metab. 2008, 93:2896-2899. 10.1210/jc.2008-0034.
81. Bagley B.N., Keane T.M., Maklakova V.I., Marshall J.G., Lester R.A., Cancel M.M., et al. A dominantly acting murine allele of Mcm4 causes chromosomal abnormalities and promotes tumorigenesis. PLoS Genet. 2012, 8(11):e1003034. 10.1371/journal.pgen.1003034.
82. Shima N., Alcaraz A., Liachko I., Buske T.R., Andrews C.A., Munroe R.J., et al. A viable allele of Mcm4 causes chromosome instability and mammary adenocarcinomas in mice. Nat. Genet. 2007, 39:93-98.
83. Romagnani C., Juelke K., Falco M., Morandi B., D'Agostino A., Costa R., et al. CD56brightCD16- killer Ig-like receptor-NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation. J. Immunol. 2007, 178:4947-4955.
84. Carson D.R., Christman M.F. Evidence that replication fork components catalyze establishment of cohesion between sister chromatids. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:8270-8275.
85. Bermudez V.P., Maniwa Y., Tappin I., Ozato K., Yokomori K., Hurwitz J. The alternative Ctf18-Dcc1-Ctf8-replication factor C complex required for sister chromatid cohesion loads proliferating cell nuclear antigen onto DNA. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:10237-10242.
86. Inoue A., Hyle J., Lechner M.S., Lahti J.M. Mammalian ChlR1 has a role in heterochromatin organization. Exp. Cell Res. 2011, 317:2522-2535. 10.1016/j.yexcr.2011.08.006.
87. Farina A., Shin J.H., Kim D.H., Bermudez V.P., Kelman Z., Seo Y.S., et al. Studies with the human cohesin establishment factor ChlR1. Association of ChlR1 with Ctf18-RFC and Fen1. J. Biol. Chem. 2008, 283:20925-20936. 10.1074/jbc.M802696200.
88. van der Lelij P., Chrzanowska K.H., Godthelp B.C., Rooimans M.A., Oostra A.B., Stumm M., et al. Warsaw breakage syndrome, a cohesinopathy associated with mutations in the XPD helicase family member DDX11/ChlR1. Am. J. Hum. Genet. 2010, 86:262-266. 10.1016/j.ajhg.2010.01.008.
89. Wu Y., Sommers J.A., Khan I., de Winter J.P., Brosh R.M. Biochemical characterization of Warsaw breakage syndrome helicase. J. Biol. Chem. 2012, 287:1007-1021. 10.1074/jbc.M111.276022.
90. Bhattacharya C., Wang X., Becker D. The DEAD/DEAH box helicase DDX11, is essential for the survival of advanced melanomas. Mol. Cancer 2012, 11:82.
91. Vasa-Nicotera M., Brouilette S., Mangino M., Thompson J.R., Braund P., Clemitson J.R., et al. Mapping of a major locus that determines telomere length in humans. Am. J. Hum. Genet. 2005, 76:147-151.
92. Frade J.M., Ovejero-Benito M.C. Neuronal cell cycle: the neuron itself and its circumstances. Cell Cycle 2015, 14:712-720. 10.1080/15384101.2015.1004937.
93. Becker E.B., Bonni A. Cell cycle regulation of neuronal apoptosis in development and disease. Prog. Neurobiol. 2004, 72:1-25.
94. Liu D.X., Greene L.A. Neuronal apoptosis at the G1/S cell cycle checkpoint. Cell Tissue Res. 2001, 305:217-228.
95. Park K.H., Hallows J.L., Chakrabarty P., Davies P., Vincent I. Conditional neuronal simian virus 40T antigen expression induces Alzheimer-like tau and amyloid pathology in mice. J. Neurosci. 2007, 27:2969-2978.
96. Wang W., Bu B., Xie M., Zhang M., Yu Z., Tao D. Neural cell cycle dysregulation and central nervous system diseases. Prog. Neurobiol. 2009, 89:1-17.
97. Bonda D.J., Evans T.A., Santocanale C., Llosá J.C., Viña J., Bajic V., et al. Evidence for the progression through S-phase in the ectopic cell cycle re-entry of neurons in Alzheimer disease. Aging (Albany, NY) 2009, 1:382-388.
98. Kalluri R., Weinberg R.A. The basics of epithelial-mesenchymal transition. J. Clin. Invest. 2009, 119:1420-1428.
99. Thiery J.P., Acloque H., Huang R.Y., Nieto M.A. Epithelial-mesenchymal transitions in development and disease. Cell 2009, 139:871-890.
100. Fu Y., Sinha M., Peterson C.L., Weng Z. The insulator binding protein CTCF positions 20 nucleosomes around its binding sites across the human genome. PLoS Genet. 2008, 4(7):e1000138.
101. Petrakis T.G., Vougas K., Gorgoulis V.G. Cdc6: a multi-functional molecular switch with critical role in carcinogenesis. Transcription 2012, 3:124-129. 10.4161/trns.20301.
102. Sun X., Cheng G., Hao M., Zheng J., Zhou X., Zhang J., et al. CXCL12/CXCR4/CXCR7 chemokine axis and cancer progression. Cancer Metastasis Rev. 2010, 29(4):709-722. 10.1007/s10555-010-9256-x.
103. Gorgoulis V.G., Zacharatos P., Kotsinas A., Kletsas D., Mariatos G., Zoumpourlis V., et al. p53 activates ICAM-1 (CD54) expression in an NF-κB-independent manner. EMBO J. 2003, 22:1567-1578. 10.1093/emboj/cdg157.
104. Gorgoulis V.G., Pratsinis H., Zacharatos P., Demoliou C., Sigala F., Asimacopoulos J.P., et al. p53-dependent ICAM-1 overexpression in senescent human cells identified in atherosclerotic lesions. Lab. Invest. 2005, 85:502-511.
105. Pateras I.S., Havaki S., Nikitopoulou X., Vougas K., Townsend P.A., Panayiotidis M.I., et al. The DNA damage response and immune signaling alliance: is it good or bad? Nature decides when and where. Pharmacol. Ther. 2015, 154:36-56. 10.1016/j.pharmthera.201506.011.
106. Edmunds J.W., Mahadevan L.C., Clayton A.L. Dynamic histone H3 methylation during gene induction: HYPB/Setd2 mediates all H3K36 trimethylation. EMBO J. 2008, 27:406-420.
107. Neuwald A.F., Aravind L., Spouge J.L., Koonin E.V. AAA+: a class of chaperone-like ATPases associated with the assembly, operation, and disassembly of protein complexes. Genome Res. 1999, 9:27-43.
108. Dominguez-Sola D., Ying C.Y., Grandori C., Ruggiero L., Chen B., Li M. Non-transcriptional control of DNA replication by c-Myc. Nature 2007, 448:445-451.
109. Steckel M., Molina-Arcas M., Weigelt B., Marani M., Warne P.H., Kuznetsov H., et al. Determination of synthetic lethal interactions in KRAS oncogene-dependent cancer cells reveals novel therapeutic targeting strategies. Cell Res. 2012, 22:1227-1245. 10.1038/cr.2012.82.
110. Natoli C., Perrucci B., Perrotti F., Falchi L., Iacobelli S. Consorzio interuniversitario nazionale per bio-oncologia (CINBO) tyrosine kinase inhibitors. Curr. Cancer Drug Targets 2010, 10:462-483.
111. Chene P. ATPases as drug targets: learning from their structure. Nat. Rev. Drug Discov. 2002, 1:665-673.
112. Schrödinger, LLC SiteMap. Version 3.4 2015, Schrödinger, LLC, New York, NY.
113. Hanahan D., Weinberg R.A. Hallmarks of cancer: next generation. Cell 2011, 144:646-674. 10.1016/j.cell.2011.02.013.
114. Blow J.J., Gillespie P.J. Replication licensing and cancer-a fatal entanglement?. Nat. Rev. Cancer 2008, 8:799-806. 10.1038/nrc2500.
115. Xie X., Lu J., Kulbokas E.J., Golub T.R., Mootha V., Lindblad-Toh K., et al. Systematic discovery of regulatory motifs in human promoters and 3'UTRs by comparison of several mammals. Nature 2005, 434:338-345.
116. Subramanian A., Tamayo P., Mootha V.K., Mukherjee S., Ebert B.L., Gillette M.A., et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:15545-15550.
117. Clijsters L., Wolthuis R. PIP-box-mediated degradation prohibits re-accumulation of Cdc6 during S phase. J. Cell Sci. 2014, 127:1336-1345. 10.1242/jcs.145862.
118. Petersen B.O., Lukas J., Sorensen C.S., Bartek J., Helin K. Phosphorylation of mammalian CDC6 by cyclin A/CDK2 regulates its subcellular localization. EMBO J. 1999, 18:396-410.
119. Mailand N., Diffley J.F. CDKs promote DNA replication origin licensing in human cells by protecting Cdc6 from APC/C-dependent proteolysis. Cell 2005, 122:915-926.
120. Elsasser S., Chi Y., Yang P., Campbell J.L. Phosphorylation controls timing of Cdc6p destruction: a biochemical analysis. Mol. Biol. Cell 1999, 10:3263-3277.
121. Saha T., Ghosh S., Vassilev A., DePamphilis M.L. Ubiquitylation phosphorylation and Orc2 modulate the subcellular location of Orc1 and prevent it from inducing apoptosis. J. Cell Sci. 2006, 119:1371-1382. 10.1242/jcs.02851.
122. Saka Y. Mathematical modeling of gene regulatory networks in Xenopus development. Methods Mol. Biol. 2012, 917:497-513. 10.1007/978-1-61779-992-1_28.
123. Fujii-Yamamoto H., Kim J.M., Arai K., Masai H. Cell cycle and developmental regulations of replication factors in mouse embryonic stem cells. J. Biol. Chem. 2005, 280:12976-12987.
124. Abbas T., Keaton M.A., Dutta A. Genomic instability in cancer. Cold Spring Harbor Perspect. Biol. 2013, 5(3):a012914. 10.1101/cshperspect.a012914.
125. Jallepalli P.V., Brown G.W., Muzi-Falconi M., Tien D., Kelly T.J. Regulation of the replication initiator protein p65cdc18 by CDK phosphorylation. Genes Dev. 1997, 11:2767-2779.
126. Zhou C., Jong A. CDC6 mRNA fluctuates periodically in the yeast cell cycle. J. Biol. Chem. 1990, 265:19904-19909.
127. Gorgoulis V.G., Zacharatos P., Mariatos G., Kotsinas A., Bouda M., Kletsas D., et al. Transcription factor E2F-1 acts as a growth-promoting factor and is associated with adverse prognosis in non-small cell lung carcinomas. J. Pathol. 2002, 198:142-156.
128. Zacharatos P., Kotsinas A., Evangelou K., Karakaidos P., Vassiliou L.V., Rezaei N., et al. Distinct expression patterns of the transcription factor E2F-1 in relation to tumour growth parameters in common human carcinomas. J. Pathol. 2004, 203:744-753. 10.1002/path.1582.
129. Evangelou K., Kotsinas A., Mariolis-Sapsakos T., Giannopoulos A., Tsantoulis P.K., Constantinides C., et al. E2F-1 overexpression correlates with decreased proliferation and better prognosis in adenocarcinomas of Barrett oesophagus. J. Clin. Pathol. 2008, 61:601-605.
130. Nishitani H., Taraviras S., Lygerou Z., Nishimoto T. The human licensing factor for DNA replication Cdt1 accumulates in G1 and is destabilized after initiation of S-phase. J. Biol. Chem. 2001, 276:44905-44911.
131. Georgakopoulou E., Tsimaratou K., Evangelou K., Fernandez M.P.J., Zoumpourlis V., Trougakos I.P., et al. Specific lipofuscin staining as a novel biomarker to detect replicative and stress-induced senescence. A method applicable in cryo-preserved and archival tissues. Aging (Albany, NY) 2013, 5:37-50.